Description:
Under current Good Manufacturing Practice guidelines, manufacturers must validate disinfectant regimens and rotation for their cleanrooms and other areas involved in the manufacture of sterile pharmaceutical products and medical devices. Charles River Singapore offers manufacturers a hassle-free approach of implementing and validating a disinfectant regimen in-house for the entire 3 phases of evaluation including qualitative evaluation of basic bactericidal / fungicidal activity (phase 1), quantitative evaluations (phase 2) and in-situ evaluations (phase 3, environmental monitoring). With our expertise in microbiological studies, Charles River Singapore is able to provide advice on selection of disinfectants for your manufacturing facility, maintaining a proper rotation schedule as well as ensuring continuous efficacy of your selected disinfectant against common environmental isolates.